DKK1 and Alzheimer disease: This inhibition of Wnt signaling by Dkk1 leads to increased Gsk3ß activity and reduced cytoplasmic ß-catenin levels – both features which are observed in the brains of AD patients (Zhang et al., 1998; Pei et al., 1999; Kawamura et al., 2001).